Top Abstract Purchase Related
Home
>
Node
>
Subnode

Action and tolerability of delayed-action buflomedil in obliterating arteriopathies of the lower limbs. a multicenter study

Andreozzi, G.M.; Lepore, R.

La Clinica Terapeutica 135(4): 273-281

1990

ISSN/ISBN: 0009-9074
PMID: 2150026
Document Number: 352092
A new buflomedil retard preparation has been evaluated in 318 patients, suffering from obliterating arterial disease of the lower limbs, for 90 days at once daily 600 mg doses. After 30 days of treatment a significant (p less than 0.001) improvement of paresthesia, hypothermia and "claudicatio intermittens" has been found. The same trend has been found after 90 days with improvement of walking distance (+ 81.1%), walking time (+ 62.1%), walking speed (+ 15.0%) as well as a significant decrease of functional recovery time (-24.6%). The AA. stress the good tolerability and compliance of this new retard preparation.

Document emailed within 1 workday
Secure & encrypted payments

Allegra, C.; Andreozzi, G.M.; Avellone, G.; Cospite, M.; Del Guercio, R.; Lepore, R.; Nuzzaci, G.; Pinto, A.; Romeo, S. 1986: Multicenter study on the therapeutic activity of buflomedil chlorhydrate in obliterative arteriopathies of the legs La Clinica Terapeutica 119(1): 25-33
Gottmann-Lückerath, I. 1983: Clinico-experimental study on the start of the pharmacological action of an oral classical antihistaminic without and with delayed-action effect on the length of effect of the delayed-action type Die Medizinische Welt 34(18): 548-551
Camuzzini, G.F.; Ferrero, S.; Tortore, P.; Belgrano, E.A.; Pili, G.; Farinelli, M.C.; D'Angeli, B. 1983: Computerized angioscintigraphy in the pre- and post-operative study of obliterating arteriopathies of the lower limbs Minerva Cardioangiologica 31(1-2): 17-26
Antignani, P.L.; Cantera, E. 1987: Nosography and risk factors in obliterating arteriopathies of the lower limbs La Clinica Terapeutica 122(6): 465-471
Raspanti, D.; Cameli, A.M.; Trapani, M.; Dorigo, D.; Mazzotta, A.; Negro, P. 1987: Medical treatment of obliterating arteriopathies of the lower limbs with vasoactive drugs La Clinica Terapeutica 121(6): 479-483
Peruzzo, L. 1974: Direct surgical treatment of chronic obliterating arteriopathies of the lower limbs Minerva Medica 65(24): 1290-1291
De Marchi, S.; Arosio, E.; Prior, M.; Zannoni, M.; Lucchese, L.; Lechi, A. 1998: Cardiopulmonary baroreceptors and peripheral resistance in patients with obliterating arteriopathies of the lower limbs Minerva Cardioangiologica 46(9): 313-314
Rengo, F.; Brevetti, G.; Bracale, G.G.; Masciariello, S.; Trimarco, B.; de Caprio, L.; Critelli, G. 1975: Behavior of some metabolic parameters during the post-ischemic phase in subjects with obliterating arteriopathies of the lower limbs Bollettino Della Societa Italiana di Cardiologia 20(12): 1795-1800
Dabizzi, R.P.; Fantini, F.; Cappelli, G.; Grandonico, F. 1970: Correlations between reactive hyperemia and response to vasodilator agents in patients with obliterating arteriopathies of the lower limbs Minerva Cardioangiologica 18(5): 287-290
Ueberbacher, H.J.; Patyna, W.D.; Krepp, P.; Puespoek, J.; Neuhaus, R.; Hilbich, K.; Bulitta, M.; Rittinghausen, R. 1991: Randomized, double-blind comparison of isosorbide-5-mononitrate and delayed-action nifedipine in patients with stable exertional angina. Multicenter Study Group Schweizerische Medizinische Wochenschrift 121(49): 1836-1840
Gibelin, P.; Camous, J.P.; Profit-Degoul, I.; Baudouy, M.; Morand, P. 1986: Efficacy and tolerability of a delayed-action vasodilator agent, cadralazine, in severe chronic cardiac failure Annales de Cardiologie et d'Angeiologie 35(2): 111-117
Longo, F.N.; Potortì, F.; Urbano, O.; Perroni, G.B. 1988: Effects of buflomedil on peripheral arteriopathies. An open clinical study Minerva Cardioangiologica 36(5): 249-252
Natali, J.; Kieny, R.; Le Bas, P.; Benhamou, M.; Molkhou, J.M. 1989: Ifenprodil tartrate in the treatment of occlusive arteriopathies of the lower limbs. Results of a prospective double-blind controlled multicenter trial Annales de Cardiologie et d'Angeiologie 38(6): 339-342
Artese, R.; De Laszlo, M.H.; Molocznik, I.; Varela, J.; Guitelman, A.; Brussino, M.; Dickmann, G.H.; Montes, M.E. 1971: Pharmacodynamic evaluation of synthetic prolonged-action ACTH on the adrenal function of patients with hypothalamo-pituitary pathology. Comparative study of synthetic ACTH and extra-delayed-action gel Prensa Medica Argentina 57(46): 2088-2097
Ziégler, M.; Rondot, P. 1999: Action of piribedil in Parkinson disease. Multicenter study Presse Medicale 28(26): 1414-1418
Frausini, G.; Rotatori, P.; Gaggi, S.; Barone, A.; Pupita, F. 1988: Digital blood flow in peripheral vascular diseases. Action of drugs: buflomedil Minerva Cardioangiologica 36(6): 319-322
Turrisi, E.; Mea, A.; Bruno, G.; Vitagliano, A. 1984: Controlled study of delayed-action fenspiride in a pneumologic milieu La Clinica Terapeutica 111(4): 339-346
Dorf, G.; Licht, H.; Namias, A.; Paraf, A. 1981: Action of Poly-Karaya in functional colopathies. Results of a multicenter study of 114 patients Medecine and Chirurgie Digestives 10(6): 533-538
Coscia, M. 1972: Effects of nicergoline in peripheral arteriopathies of the lower limbs. Double-blind study Minerva Cardioangiologica 20(9): 497-504
Tallarida, G.; Baldoni, F.; Peruzzi, G.; Raimondi, G.; Grimaldi, I.; Visigalli, G.; Gristina, S.; Massaro, M.; De Martinis, L.; Sangiorgi, M. 1983: Effects of the administration of buflomedil-hydrochloride on the arterial circulation of the legs in patients with obliterative arteriopathies Cardiologia 28(8): 651-660